Repligen CORP Form 4 insider transactions
NASDAQ
RGEN
Repligen CORPRepligen Director Karen A Dawes sold 275 shares of common stock at $161 per share under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
RGEN
Repligen CORPRepligen Corp. Director Glenn P. Muir exercised 3,366 stock options at $26.12 per share, increasing direct common stock ownership to 36,622 shares.
NASDAQ
RGEN
Repligen CORPRepligen Director Anthony Hunt reported a transfer of 2,000 common shares, reducing his direct beneficial ownership to 98,959 shares.
NASDAQ
RGEN
Repligen CORPRepligen CEO Olivier Loeillot sold 7,041 shares of common stock for $170 per share on November 25, 2025, under a pre-arranged trading plan.
NASDAQ
RGEN
Repligen CORPRepligen's Chief Operating Officer, James Bylund, sold 2,191 shares of common stock for approximately $151.21 per share under a pre-arranged plan.
NASDAQ
RGEN
Repligen CORPAnthony Hunt, a director at Repligen Corp, reported the sale of 19,000 common shares and the exercise of options for 2,952 shares on November 13, 2025.
NASDAQ
RGEN
Repligen CORPRepligen Director Anthony Hunt exercised stock options and subsequently sold a portion of his common stock holdings under a pre-arranged 10b5-1 trading plan.
NASDAQ
RGEN
Repligen CORPRepligen CEO Olivier Loeillot disposed of 1,248 shares of common stock to cover tax obligations related to restricted stock units.
NASDAQ
RGEN
Repligen CORPRepligen's Chief Financial Officer, Jason K. Garland, disposed of 412 shares of common stock to cover tax withholding obligations related to restricted stock units.
NASDAQ
RGEN
Repligen CORPRepligen Corp Director Anthony Hunt exercised stock options and subsequently sold a portion of his common stock holdings as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
RGEN
Repligen CORPRepligen's Chief Accounting Officer, Violetta Hughes, received awards of 4,142 restricted stock units and 3,914 stock options.
NASDAQ
RGEN
Repligen CORPRepligen CEO Olivier Loeillot disposed of 2,506 shares of common stock to cover tax obligations related to restricted stock units.
NASDAQ
RGEN
Repligen CORPRepligen Corporation Director Martin D. Madaus acquired 1,800 shares of common stock at an average price of $112.128 through a pre-arranged trading plan.
NASDAQ
RGEN
Repligen CORPDirector Nicolas Barthelemy reports the acquisition of restricted stock units and stock options in Repligen Corp.
NASDAQ
RGEN
Repligen CORPKonstantin Konstantinov, a director at Repligen Corp, reported the acquisition of stock options and restricted stock units in a recent SEC filing.
NASDAQ
RGEN
Repligen CORPForm 4: Repligen Corp Director Glenn P. Muir Reports Acquisition of Restricted Stock Units and Stock Options
Director Glenn P. Muir reports acquisition of 973 restricted stock units and 1,800 stock options in Repligen Corp.
NASDAQ
RGEN
Repligen CORPCarrie Eglinton Manner, a director at Repligen Corp, reported the acquisition of restricted stock units and stock options.
NASDAQ
RGEN
Repligen CORPDirector Karen A. Dawes reports acquisition of restricted stock units and stock options in Repligen Corporation.
NASDAQ
RGEN
Repligen CORPDirector Martin D. Madaus reports the acquisition of restricted stock units and stock options in Repligen Corporation.
NASDAQ
RGEN
Repligen CORPDirector Margaret Pax reports the acquisition of restricted stock units and stock options in Repligen Corporation.
NASDAQ
RGEN
Repligen CORPDirector Rohin Mhatre reports the acquisition of restricted stock units and stock options in Repligen Corporation.
NASDAQ
RGEN
Repligen CORPDirector Anthony Hunt of Repligen Corp sold a significant number of shares on May 15, 2025, under a pre-arranged 10b5-1 trading plan.
NASDAQ
RGEN
Repligen CORPChief Operating Officer James Bylund reports a transaction involving Repligen Corp common stock to cover tax obligations.
NASDAQ
RGEN
Repligen CORPJames Bylund, Chief Operating Officer of Repligen Corp, reports acquisition and disposal of common stock related to performance stock units.
NASDAQ
RGEN
Repligen CORPDirector Anthony Hunt of Repligen Corp reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.
NASDAQ
RGEN
Repligen CORPDirector Margaret Pax reported a transaction involving Repligen Corp (RGEN) common stock on March 17, 2025.
NASDAQ
RGEN
Repligen CORPRepligen's CFO, Jason K. Garland, reports the acquisition of restricted stock units and stock options, as well as the disposal of common stock.
NASDAQ
RGEN
Repligen CORPSenior VP of R&D at Repligen Corp, Ralf Kuriyel, reports acquisition of restricted stock units and stock options, along with a disposition of shares to cover tax obligations.
NASDAQ
RGEN
Repligen CORPDirector Anthony Hunt disposed of 10,142 shares of Repligen Corp to cover tax obligations arising from the release of restricted stock units.
NASDAQ
RGEN
Repligen CORPJames Bylund, Chief Operating Officer of Repligen Corp, reports acquisition of restricted stock units and stock options, as well as disposition of shares to cover tax obligations.